Funding Briefs

Grants For AIDS Research From AmFAR The American Foundation for AIDS Research (AmFAR) offers one-year research grants, as well as short-term travel grants, for biomedical research on AIDS. The research grants provide up to $50,000 for direct costs, plus up to an additional 20 percent of the grant amount for institutional indirect costs. Smaller travel grants of up to $5,000 finance short periods of study or specialized training. Postdoctoral investigators who are affiliated with nonprofit ins

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Grants For AIDS Research From AmFAR

The American Foundation for AIDS Research (AmFAR) offers one-year research grants, as well as short-term travel grants, for biomedical research on AIDS. The research grants provide up to $50,000 for direct costs, plus up to an additional 20 percent of the grant amount for institutional indirect costs. Smaller travel grants of up to $5,000 finance short periods of study or specialized training.

Postdoctoral investigators who are affiliated with nonprofit institutions are eligible to apply for both awards. Grants are intended for institutions in the United States or its territories, but foreign institutions are eligible for travel grants for study in the U.S.

Letters of intent (mandatory) are due by April 9 for both awards. Approximately 100 of the letters of intent will be chosen for submission of full applications. Researchers must choose from 28 categories (Topic Assignment Codes) that best match their chosen research, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies